Iroquois Capital Management, LLC - 15 Jul 2025 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)

Filing Manager
Iroquois Capital Management, LLC
Reporting Manager
Richard Abbe
Security
BriaCell Therapeutics Corp. Common Shares, no par value
Symbol
BCTX
Shares outstanding
17,582,418 shares
Disclosed Ownership
1,600,000 shares
Ownership
9.1%
Form type
SCHEDULE 13G
Filing time
28 Jul 2025, 11:38:34 UTC
Date of event
15 Jul 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Iroquois Capital Management, LLC 3.2% 560,000 0 560,000 /s/ Richard Abbe Richard Abbe, President
Richard Abbe 9.1% 1,600,000 1,040,000 560,000 /s/ Richard Abbe Richard Abbe
Kimberly Page 3.2% 560,000 0 560,000 /s/ Kimberly Page Kimberly Page